These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 31030373)

  • 41. Cancer stem cells and the tumor microenvironment: interplay in tumor heterogeneity.
    Albini A; Bruno A; Gallo C; Pajardi G; Noonan DM; Dallaglio K
    Connect Tissue Res; 2015; 56(5):414-25. PubMed ID: 26291921
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Relationship between Exosomes and Cancer: Implications for Diagnostics and Therapeutics.
    Weston WW; Ganey T; Temple HT
    BioDrugs; 2019 Apr; 33(2):137-158. PubMed ID: 30810948
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Exosome: emerging biomarker in breast cancer.
    Jia Y; Chen Y; Wang Q; Jayasinghe U; Luo X; Wei Q; Wang J; Xiong H; Chen C; Xu B; Hu W; Wang L; Zhao W; Zhou J
    Oncotarget; 2017 Jun; 8(25):41717-41733. PubMed ID: 28402944
    [TBL] [Abstract][Full Text] [Related]  

  • 44. M2 Macrophage-Derived Exosomes Promote Cell Migration and Invasion in Colon Cancer.
    Lan J; Sun L; Xu F; Liu L; Hu F; Song D; Hou Z; Wu W; Luo X; Wang J; Yuan X; Hu J; Wang G
    Cancer Res; 2019 Jan; 79(1):146-158. PubMed ID: 30401711
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Exosomes and tumor-mediated immune suppression.
    Whiteside TL
    J Clin Invest; 2016 Apr; 126(4):1216-23. PubMed ID: 26927673
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CD44v6 is a marker of constitutive and reprogrammed cancer stem cells driving colon cancer metastasis.
    Todaro M; Gaggianesi M; Catalano V; Benfante A; Iovino F; Biffoni M; Apuzzo T; Sperduti I; Volpe S; Cocorullo G; Gulotta G; Dieli F; De Maria R; Stassi G
    Cell Stem Cell; 2014 Mar; 14(3):342-56. PubMed ID: 24607406
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fibroblast-Derived Exosomes Contribute to Chemoresistance through Priming Cancer Stem Cells in Colorectal Cancer.
    Hu Y; Yan C; Mu L; Huang K; Li X; Tao D; Wu Y; Qin J
    PLoS One; 2015; 10(5):e0125625. PubMed ID: 25938772
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Exosomal tetraspanins as regulators of cancer progression and metastasis and novel diagnostic markers.
    Malla RR; Pandrangi S; Kumari S; Gavara MM; Badana AK
    Asia Pac J Clin Oncol; 2018 Dec; 14(6):383-391. PubMed ID: 29575602
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cell surface tetraspanin Tspan8 contributes to molecular pathways of exosome-induced endothelial cell activation.
    Nazarenko I; Rana S; Baumann A; McAlear J; Hellwig A; Trendelenburg M; Lochnit G; Preissner KT; Zöller M
    Cancer Res; 2010 Feb; 70(4):1668-78. PubMed ID: 20124479
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Exosomes: The protagonists in the tale of colorectal cancer?
    Nabariya DK; Pallu R; Yenuganti VR
    Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188426. PubMed ID: 32956762
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Exosomes: Emerging Insights into the Progression of Pancreatic Cancer.
    Zhou X; Yan Y; Shen Y; Xu M; Xu W
    Int J Biol Sci; 2024; 20(10):4098-4113. PubMed ID: 39113699
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lgr5+CD44+EpCAM+ Strictly Defines Cancer Stem Cells in Human Colorectal Cancer.
    Leng Z; Xia Q; Chen J; Li Y; Xu J; Zhao E; Zheng H; Ai W; Dong J
    Cell Physiol Biochem; 2018; 46(2):860-872. PubMed ID: 29627827
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Emerging functional markers for cancer stem cell-based therapies: Understanding signaling networks for targeting metastasis.
    Marquardt S; Solanki M; Spitschak A; Vera J; Pützer BM
    Semin Cancer Biol; 2018 Dec; 53():90-109. PubMed ID: 29966677
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Biomolecular characterization of exosomes released from cancer stem cells: Possible implications for biomarker and treatment of cancer.
    Kumar D; Gupta D; Shankar S; Srivastava RK
    Oncotarget; 2015 Feb; 6(5):3280-91. PubMed ID: 25682864
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The potential roles of exosomes in pancreatic cancer initiation and metastasis.
    Sun W; Ren Y; Lu Z; Zhao X
    Mol Cancer; 2020 Sep; 19(1):135. PubMed ID: 32878635
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of pancreatic cancer-derived exosomes in salivary biomarker development.
    Lau C; Kim Y; Chia D; Spielmann N; Eibl G; Elashoff D; Wei F; Lin YL; Moro A; Grogan T; Chiang S; Feinstein E; Schafer C; Farrell J; Wong DT
    J Biol Chem; 2013 Sep; 288(37):26888-97. PubMed ID: 23880764
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The epithelial to mesenchymal transition (EMT) and cancer stem cells: implication for treatment resistance in pancreatic cancer.
    Zhou P; Li B; Liu F; Zhang M; Wang Q; Liu Y; Yao Y; Li D
    Mol Cancer; 2017 Feb; 16(1):52. PubMed ID: 28245823
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Colon cancer stem cell markers CD44 and CD133 in patients with colorectal cancer and synchronous hepatic metastases.
    Jing F; Kim HJ; Kim CH; Kim YJ; Lee JH; Kim HR
    Int J Oncol; 2015 Apr; 46(4):1582-8. PubMed ID: 25625240
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tumor-Derived Exosomes in Tumor-Induced Immune Suppression.
    Hao Q; Wu Y; Wu Y; Wang P; Vadgama JV
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163380
    [TBL] [Abstract][Full Text] [Related]  

  • 60. c-Met and PD-L1 on Circulating Exosomes as Diagnostic and Prognostic Markers for Pancreatic Cancer.
    Lux A; Kahlert C; Grützmann R; Pilarsky C
    Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31284422
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.